Wells Fargo initiated coverage of KKR with a rating of Equal Weight and set a new price target of $130.00
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 6/30/2025 | $150.00 | Overweight | Piper Sandler |
| 5/14/2025 | $150.00 | Equal-Weight → Overweight | Morgan Stanley |
| 4/15/2025 | $119.00 | Hold → Buy | HSBC Securities |
| 3/20/2025 | $150.00 → $141.00 | Equal Weight → Overweight | Wells Fargo |
| 1/30/2025 | $173.00 | Buy → Hold | HSBC Securities |
| 9/18/2024 | $148.00 | Buy | HSBC Securities |
| 9/12/2024 | $130.00 | Equal Weight | Wells Fargo |
| 8/27/2024 | $153.00 | Buy | Redburn Atlantic |
Ascend Asia is led by Tomas Urbanec, former CEO of Prudential Singapore finexis joins as first member of platform KKR, a leading global investment firm, today announced the launch of Ascend Asia Financial Services Group ("Ascend Asia"), a newly established financial advisory platform in Singapore. Concurrently, Ascend Asia, through funds managed by KKR, has entered into definitive agreements to acquire finexis advisory and its affiliates (together, "finexis"), marking finexis as the platform's inaugural member firm. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250630866461/en/ Ascend Asia is the first platform in Singapore
Acquisition to be followed by merger; strengthens Torrent's IPM market presence Torrent Pharmaceuticals Limited ("Torrent") and global investment firm KKR today announced that Torrent has entered into definitive agreements to acquire controlling stake in J. B. Chemicals and Pharmaceuticals ("JB Pharma") from KKR at an Equity Valuation of INR 25,689 crores (on fully diluted basis), followed by a merger of the two entities. The transaction marks a significant step in Torrent's ambition to create a future-ready, diversified healthcare platform combining a deep chronic segment heritage with emerging international CDMO capabilities. This press release features multimedia. View the full releas
KKR today announced a monetization activity update for the period from April 1, 2025 to June 20, 2025. Based on information available to us as of today, with respect to the period through June 20, 2025, KKR's Asset Management segment has earned total realized performance income and total realized investment income in excess of $475 million. This amount includes performance income that is expected to be crystallized at June 30, 2025.(1) The monetization activity quarter-to-date in second quarter 2025 is made up of approximately 75% realized performance income and approximately 25% realized investment income. The quarter-to-date monetization activity is driven by a combination of public secon
Piper Sandler initiated coverage of KKR with a rating of Overweight and set a new price target of $150.00
Morgan Stanley upgraded KKR from Equal-Weight to Overweight and set a new price target of $150.00
HSBC Securities upgraded KKR from Hold to Buy and set a new price target of $119.00
4 - KKR & Co. Inc. (0001404912) (Reporting)
4 - KKR & Co. Inc. (0001404912) (Reporting)
4 - KKR & Co. Inc. (0001404912) (Issuer)